Pomalyst is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma that has progressed after being treated with other therapies. Pomalyst is often combined with a corticosteroid, often dexamethasone, to treat myeloma. Pomalyst is also known by its drug name, pomalidomide.
Pomalyst is an immunomodulator — a drug that modulates the immune system. It is unknown how Pomalyst works to fight myeloma, but it may prevent the growth of new blood vessels that supply tumors.
How do I take it?
Pomalyst is taken orally on days 1 through 21 in a 28-day cycle.
Pomalyst comes in the form of a capsule.
The FDA-approved label for Pomalyst lists common side effects including fatigue, low bood count, constipation, nausea, diarrhea, infections of the upper respiratory tract, back pain, and fever.
Rare but serious side effects listed for Pomalyst include liver failure, blood toxicity, tumor lysis syndrome, hypersensitivity, and severe skin reactions.
For more details about this treatment, visit:
Pomalyst — Celgene
Drug Therapy for Multiple Myeloma — American Cancer Society